Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
21
0
4

Year Published

1998
1998
2012
2012

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(25 citation statements)
references
References 4 publications
0
21
0
4
Order By: Relevance
“…It also allows weaning to be attempted over several hours to days if the bridging tube is added to the circuit. According to the data concerning the FM, which tends to recover within 2 weeks, 5,8,10,22,23 it is also reasonable to employ ECMO for the treatment of FM with shock beyond medical management.…”
Section: Discussionmentioning
confidence: 99%
“…It also allows weaning to be attempted over several hours to days if the bridging tube is added to the circuit. According to the data concerning the FM, which tends to recover within 2 weeks, 5,8,10,22,23 it is also reasonable to employ ECMO for the treatment of FM with shock beyond medical management.…”
Section: Discussionmentioning
confidence: 99%
“…McCarthy et al reported that patients with fulminant myocarditis have better long-term survival than those with acute myocarditis, 7 but they used the classification system of Felker et al 15 and their study includes only 2 cases of fulminant myocarditis treated with circulatory assist devices. Rockman et al reported that LV assist devices improve the prognosis of fulminant myocarditis, [20][21][22] but these devices require an operation performed by cardiovascular surgeons and are not suitable for emergency situations such as cardiac arrest or ventricular fibrillation. Therefore, we studied the long-term prognosis of the patients of fulminant myocarditis who required PCPS by comparing them with patients with acute myocarditis who did not required PCPS and our results strongly support the hypothesis that the long-term prognosis of patients of fulminant myocarditis who are treated by PCPS and survive the acute phase crisis is favorable.…”
Section: Discussionmentioning
confidence: 99%
“…82 The drive system is capable of applying systolic pressures of 50-300 mmHg and diastolic pressures of 21 to 299 mmHg with systolic times of 20-50% and pulse rates of 40-180 BPM depending on the pump size. 42 The three-leaflet valves in the inflow and outflow tracts, and the seamless transparent pump casing, are made of biocompatible polyurethane. 81 Similar to most first generation devices, flow paths through the device appear sub-optimal which commonly leads to thrombus formation in the outflow tracts of both LVADs and RVADs.…”
Section: Medos Hia-vadmentioning
confidence: 99%